HSPA5 and glioblastoma: Given these data and those on TMZ induction of gene delivery by RGD4C/AAVP‐Grp78‐Luc vector, we selected RGD4C/AAVP‐Grp78‐HSVtk/GCV as most suitable for in vivo studies and therapy combination with TMZ against orthotopic GBM.